PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) Shareholders’ equity 2022–2025
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT) shareholders’ equity at each fiscal year-end, per SEC filings.
-$6.3MFY2025 · since FY2022: -$6.2M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | -5.7% |
| FY2024 | -$6.0M | +21.5% |
| FY2023 | -$7.6M | -21.9% |
| FY2022 | -$6.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice